WallStSmart
VTVT

vTv Therapeutics Inc

NASDAQ: VTVT · HEALTHCARE · BIOTECHNOLOGY

$32.24
+3.10% today

Updated 2026-04-30

Market cap
$125.92M
P/E ratio
P/S ratio
14,852.65x
EPS (TTM)
$-3.20
Dividend yield
52W range
$14 – $44
Volume
0.1M

vTv Therapeutics Inc (VTVT) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
+15.5%
Last 4 quarters
Revenue YoY growth
-241.2%
Most recent quarter
EPS YoY growth
-5.1%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+4.5%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+7.3%
2025-11-06
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2025-12-31$-0.58+46.7%$38.98$39.60+1.6%
2025-11-06$-1.08-8.0%$24.24$26.02+7.3%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-1.09$-0.58+46.7%$-24000.00-241.2%
2025-09-30$-1.00$-1.08-8.0%
2025-06-30$-1.12$-0.92+17.9%
2025-03-31$-0.82$-0.77+5.5%
2024-12-31$-0.87$-0.55+36.6%$17000.00-288.9%
2024-09-30$-0.88
2024-06-30$-0.81
2024-03-31$-1.17$1.00M
2023-12-31$-0.07$-1.67-2285.7%$-9000.00
2023-09-30$-0.08$-3.20-3900.0%
2023-06-30$-0.07$-0.07+0.0%$9000.00
2023-03-31$-0.09$-0.06+33.3%

Frequently asked questions

Has vTv Therapeutics Inc beaten earnings estimates?
vTv Therapeutics Inc has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of +15.5% over the last 4 quarters.
How does VTVT stock react to earnings?
VTVT stock has moved an average of +4.5% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.
What is vTv Therapeutics Inc's revenue growth rate?
vTv Therapeutics Inc reported year-over-year revenue growth of -241.2% in its most recent quarter, with EPS growing -5.1% year-over-year.